+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

From
From
CAR T-cell Therapy - Global Strategic Business Report 2026 - Product Thumbnail Image

CAR T-cell Therapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 84 Pages
  • Global
From
From
From
PEGylated Proteins - Global Strategic Business Report 2026 - Product Thumbnail Image

PEGylated Proteins - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 228 Pages
  • Global
From
In Vitro Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

In Vitro Toxicology Testing - Global Strategic Business Report

  • Report
  • November 2026
  • 460 Pages
  • Global
From
Aptamers - Global Strategic Business Report - Product Thumbnail Image

Aptamers - Global Strategic Business Report

  • Report
  • November 2026
  • 248 Pages
  • Global
From
Compound Management - Global Strategic Business Report 2026 - Product Thumbnail Image

Compound Management - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 234 Pages
  • Global
From
Biosimulation Technology - Global Strategic Business Report 2026 - Product Thumbnail Image

Biosimulation Technology - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 154 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 409 Pages
  • Global
From
High Content Screening (HCS) - Global Strategic Business Report - Product Thumbnail Image

High Content Screening (HCS) - Global Strategic Business Report

  • Report
  • November 2026
  • 357 Pages
  • Global
From
ADME-Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

ADME-Toxicology Testing - Global Strategic Business Report

  • Report
  • November 2026
  • 472 Pages
  • Global
From
High Throughput Screening (HTS) - Global Strategic Business Report - Product Thumbnail Image

High Throughput Screening (HTS) - Global Strategic Business Report

  • Report
  • November 2026
  • 284 Pages
  • Global
From
Bioengineered Protein Drugs - Global Strategic Business Report - Product Thumbnail Image

Bioengineered Protein Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 617 Pages
  • Global
From
Contract Research Outsourcing - Global Strategic Business Report - Product Thumbnail Image

Contract Research Outsourcing - Global Strategic Business Report

  • Report
  • November 2026
  • 453 Pages
  • Global
From
Drug Discovery Technologies - Global Strategic Business Report - Product Thumbnail Image

Drug Discovery Technologies - Global Strategic Business Report

  • Report
  • November 2026
  • 486 Pages
  • Global
From
From
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more